Farzad Najafipour

8PUBLICATIONS
19CO-AUTHORS
Nutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMolecular targetsMacroeconomics (incl. monetary and fiscal theory)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 19, 2026
Serum 25(OH)D concentration and risk of all-cause and cause-specific mortality in patients with chronic kidney disease: systematic review and dose-response meta-analysis of observational cohort studies.

Sonya Karimi Hacheso, Sina Naghshi, Sevil Kiani

|Dec 03, 2025
The Long-Term Effects of Postoperative Radiotherapy in Acromegaly: Results From a Single-Center Acromegaly Registry in Iran.

Farzad Najafipour, Javad Jafarpour, Amir Bahrami

|Nov 13, 2025
Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome.

Asal Ebrahimian, Afshin Moradi, Vahid Kheyri

|Mar 05, 2025
The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial.

Mostafa Najafipour, Farzad Najafipour, Alireza Ostadrahimi

|Feb 24, 2023
Economic burden of type 2 diabetes in Iran: A cost-of-illness study.

Habib Jalilian, Somayeh Heydari, Ali Imani

|Oct 24, 2022
What hematological and endocrinal indicators are important in COVID-19 infection?

Alireza Ostadrahimi, Vahideh Sadra, Amir Bahrami

Pageof 2

Frequent Collaborators

4 joint publications

Helda Tutunchi

3 joint publications

Vahideh Sadra

3 joint publications

Mostafa Najafipour

2 joint publications

Majid Mobasseri